NEW DIRECTIONS IN PHARMACOGENETICS AND ECOGENETICS

药物遗传学和生态遗传学的新方向

• 批准号: 6032045
• 负责人: WENDELL W WEBER
• 金额: $ 1.5万
• 依托单位: UNIVERSITY OF MICHIGAN AT ANN ARBOR
• 依托单位国家: 美国
• 财政年份: 1999
• 资助国家: 美国
• 起止时间: 1999-08-01 至 2000-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6032045
• 关键词: gene environment interaction; meeting /conference /symposium; pharmacogenetics; travel

This international conference addresses three new areas of pharmacogenetic and ecogenetic importance: 1) Foods and dietary constituents; 2) Genetic defenses against infections; and 3) Responses to drugs and environmental toxicants. The latter topic is subdivided in two parts which address New directions in the genetic and functional analysis of pharmacogenetic variants, and Considerations relevant to diagnostic pharmacogenetic testing: Optimizing drug discovery and drug therapy. The conference objective is a) to explore and document recent advances in pharmacogenetics and ecogenetics that will yield improved health care for large segments of human populations, and b) to facilitate the interaction of basic and clinical scientists engaged in the design and implementation of new technologies capable of screening for traits of pharmacogenetic and ecogenetic importance among subjects involved in clinical trials of new drugs and hospital patients. The speakers are of national and international caliber at the cutting edge of their topic. Some have established reputations in pharmacogenetics and ecogenetics, but we have also sought a balance that includes investigators from other fields. The roster of speakers includes a number of younger investigators who are contributing to the remarkable advances in research of potential pharmacogenetic and ecogenetic interest and to the utilization of the new knowledge in the discovery of new drugs and improved patient care.

本次国际会议讨论了药物遗传学和生态遗传学重要性的三个新领域：1)食品和膳食成分；2)遗传防御感染；3)对药物和环境毒物的反应。后一个主题被细分为两个部分，其中涉及药物遗传变异的遗传和功能分析的新方向，以及与诊断药物遗传测试相关的考虑：优化药物发现和药物治疗。会议的目标是a)探索和记录药物遗传学和生态遗传学的最新进展，这些进展将为大部分人群提供更好的医疗保健；b)促进参与设计和实施新技术的基础和临床科学家之间的互动，这些新技术能够筛选新药临床试验和医院患者中药物遗传学和生态遗传学的重要特征。演讲者在各自主题的前沿具有国内和国际水平。有些人在药物遗传学和生态遗传学方面已经建立了声誉，但我们也寻求平衡，包括来自其他领域的研究人员。演讲者名单包括一些年轻的研究人员，他们在潜在的药物遗传学和生态遗传学研究方面取得了显著进展，并在发现新药和改善患者护理方面利用了新知识。